Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel R Reed

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Current Hematologic Malignancy Reports|May 10, 2022
Targeting Apoptosis in ALLWesley M Smith, Daniel R Reed
Expert Opinion on Biological Therapy|July 29, 2024
Looking ahead to CD3, T-cell engager bispecific antibodies for hematological malignanciesDaniel R Reed, Lawrence G Lum
Cancer Management and Research|September 12, 2019
A prospective study on urine alkalization with an oral regimen consisting of sodium bicarbonate and acetazolamide in patients receiving high-dose methotrexateDaniel R Reed, Eric J Pierce, Jeremy M Sen, et al.
Cancer Management and Research|October 1, 2019
Enasidenib in acute myeloid leukemia: clinical development and perspectives on treatmentDaniel R Reed, Ramey Z Elsarrag, Amy L Morris, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 28, 2020
Gilteritinib: An FMS-like tyrosine kinase 3/AXL tyrosine kinase inhibitor for the treatment of relapsed or refractory acute myeloid leukemia patientsDaniel R Reed, Jeremy M Sen, Eric J Pierce, et al.
Clinical Trials (London, England)|January 11, 2021
Adapting isotonic dose-finding to a dynamic set of drug combinations with application to a phase I leukemia trialNolan A Wages, Daniel R Reed, Michael K Keng, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 18, 2019
Treatment of Refractory ALK Rearranged Anaplastic Large Cell Lymphoma With AlectinibDaniel R Reed, Richard D Hall, Ryan D Gentzler, et al.
International Journal of Radiation Oncology, Biology, Physics|August 23, 2005
Intraoperative fluoroscopic dose assessment in prostate brachytherapy patientsDaniel R Reed, Kent E Wallner, Sreeram Narayanan, et al.
International Journal of Radiation Oncology, Biology, Physics|September 3, 2005
Effect of post-implant edema on prostate brachytherapy treatment marginsDaniel R Reed, Kent Wallner, Eric Ford, et al.
International Journal of Radiation Oncology, Biology, Physics|January 26, 2005
Axillary lymph node dose with tangential breast irradiationDaniel R Reed, Skyler Karen Lindsley, Gary N Mann, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Current Hematologic Malignancy Reports|May 10, 2022
Targeting Apoptosis in ALLWesley M Smith, Daniel R Reed
Expert Opinion on Biological Therapy|July 29, 2024
Looking ahead to CD3, T-cell engager bispecific antibodies for hematological malignanciesDaniel R Reed, Lawrence G Lum
Cancer Management and Research|September 12, 2019
A prospective study on urine alkalization with an oral regimen consisting of sodium bicarbonate and acetazolamide in patients receiving high-dose methotrexateDaniel R Reed, Eric J Pierce, Jeremy M Sen, et al.
Cancer Management and Research|October 1, 2019
Enasidenib in acute myeloid leukemia: clinical development and perspectives on treatmentDaniel R Reed, Ramey Z Elsarrag, Amy L Morris, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 28, 2020
Gilteritinib: An FMS-like tyrosine kinase 3/AXL tyrosine kinase inhibitor for the treatment of relapsed or refractory acute myeloid leukemia patientsDaniel R Reed, Jeremy M Sen, Eric J Pierce, et al.
Clinical Trials (London, England)|January 11, 2021
Adapting isotonic dose-finding to a dynamic set of drug combinations with application to a phase I leukemia trialNolan A Wages, Daniel R Reed, Michael K Keng, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 18, 2019
Treatment of Refractory ALK Rearranged Anaplastic Large Cell Lymphoma With AlectinibDaniel R Reed, Richard D Hall, Ryan D Gentzler, et al.
International Journal of Radiation Oncology, Biology, Physics|August 23, 2005
Intraoperative fluoroscopic dose assessment in prostate brachytherapy patientsDaniel R Reed, Kent E Wallner, Sreeram Narayanan, et al.
International Journal of Radiation Oncology, Biology, Physics|September 3, 2005
Effect of post-implant edema on prostate brachytherapy treatment marginsDaniel R Reed, Kent Wallner, Eric Ford, et al.
International Journal of Radiation Oncology, Biology, Physics|January 26, 2005
Axillary lymph node dose with tangential breast irradiationDaniel R Reed, Skyler Karen Lindsley, Gary N Mann, et al.
Pageof 3